Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-061794
Filing Date
2025-06-23
Accepted
2025-06-23 18:26:43
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518376-7_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2518376-7_3seq1.xml 3 6418
2 EXHIBIT 24 tm2518376d7_ex24.htm EX-24 6659
  Complete submission text file 0001104659-25-061794.txt   14519
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ZELTIQ AESTHETICS INC. 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588
Business Address
Brumm Joshua T (Reporting) CIK: 0001528826 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 251066201